These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39055707)

  • 1. Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C.
    Morrone A; Fiorilli V; Cinti L; Roberto P; Ferri AL; Visentini M; Pulsoni A; Spinelli FR; De Santis A; Antonelli G; Basili S; Tosti ME; Conti F; Casato M
    Front Immunol; 2024; 15():1411146. PubMed ID: 39055707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent delayed spontaneous seroclearance of hepatitis B virus after incident HBV infection among adult high-risk groups.
    van Santen DK; Boyd A; Bruisten S; Sonder GJ; Prins M; van Houdt R
    J Viral Hepat; 2020 Jan; 27(1):81-87. PubMed ID: 31520430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
    Reddy A; May E; Ehrinpreis M; Mutchnick M
    World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
    Yeh ML; Hung CH; Huang JF; Liu CJ; Lee CM; Dai CY; Wang JH; Lin ZY; Lu SN; Hu TH; Yu ML; Kao JH; Chuang WL; Chen PJ; Chen DS
    PLoS One; 2011; 6(6):e20752. PubMed ID: 21695152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
    Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
    J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
    Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
    Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.
    Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL;
    J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C virus infection in Crohn's disease.
    Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
    Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
    Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
    Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
    Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
    Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus.
    Thiers V; Pol S; Persico T; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
    J Viral Hepat; 1998 Mar; 5(2):123-30. PubMed ID: 9572037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.
    Shetty K; Hussain M; Nei L; Reddy KR; Lok AS
    Liver Transpl; 2008 Apr; 14(4):534-40. PubMed ID: 18324677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance.
    Akuta N; Suzuki F; Kobayashi M; Hosaka T; Fujiyama S; Kawamura Y; Sezaki H; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2018 Oct; 90(10):1586-1592. PubMed ID: 29896794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
    J Hepatol; 1996 Mar; 24(3):271-6. PubMed ID: 8778192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.